Symbotic Announces Acquisition of OhmniLabs
Symbotic Inc. (Nasdaq: SYM) has completed the acquisition of OhmniLabs, a Silicon Valley-based robotics solutions company specializing in healthcare automation. The strategic acquisition combines Symbotic's expertise in large-scale automation with OhmniLabs' mobile robots, vision, and A.I. solutions.
Founded in 2015, OhmniLabs is known for its autonomous disinfection and telepresence robots, featuring an in-house development and manufacturing model. The acquisition aims to expand Symbotic's capabilities beyond warehouse automation while strengthening its position in healthcare industry innovation.
Symbotic Inc. (Nasdaq: SYM) ha completato l'acquisizione di OhmniLabs, un'azienda di soluzioni robotiche con sede nella Silicon Valley, specializzata nell'automazione sanitaria. Questa acquisizione strategica combina l'esperienza di Symbotic nell'automazione su larga scala con i robot mobili, le soluzioni visive e A.I. di OhmniLabs.
Fondata nel 2015, OhmniLabs è conosciuta per i suoi robot autonomi per la disinfezione e la telepresenza, con un modello di sviluppo e produzione interno. L'acquisizione mira ad ampliare le capacità di Symbotic oltre l'automazione dei magazzini, rafforzando al contempo la sua posizione nell'innovazione del settore sanitario.
Symbotic Inc. (Nasdaq: SYM) ha completado la adquisición de OhmniLabs, una empresa de soluciones robóticas con sede en Silicon Valley, especializada en la automatización sanitaria. Esta adquisición estratégica combina la experiencia de Symbotic en automatización a gran escala con los robots móviles, la visión y las soluciones A.I. de OhmniLabs.
Fundada en 2015, OhmniLabs es conocida por sus robots autónomos de desinfección y telepresencia, que cuentan con un modelo de desarrollo y fabricación interno. La adquisición tiene como objetivo expandir las capacidades de Symbotic más allá de la automatización de almacenes, al tiempo que refuerza su posición en la innovación de la industria de la salud.
Symbotic Inc. (Nasdaq: SYM)은 실리콘밸리에 본사를 둔 로봇 솔루션 회사인 OhmniLabs를 인수 완료했습니다. 이 전략적 인수는 Symbotic의 대규모 자동화 전문성과 OhmniLabs의 이동 로봇, 비전 및 AI 솔루션을 결합합니다.
2015년에 설립된 OhmniLabs는 자율 소독 및 원격 존재 로봇으로 알려져 있으며, 내부 개발 및 제조 모델을 특징으로 합니다. 이 인수는 Symbotic의 기능을 창고 자동화를 넘어 확장하고 의료 산업 혁신에서의 입지를 강화하는 것을 목표로 합니다.
Symbotic Inc. (Nasdaq: SYM) a terminé l'acquisition de OhmniLabs, une entreprise de solutions robotiques basée à Silicon Valley, spécialisée dans l'automatisation de la santé. Cette acquisition stratégique combine l'expertise de Symbotic en automatisation à grande échelle avec les robots mobiles, les solutions de vision et d'IA d'OhmniLabs.
Fondée en 2015, OhmniLabs est connue pour ses robots autonomes de désinfection et de téléprésence, avec un modèle de développement et de fabrication interne. L'acquisition vise à élargir les capacités de Symbotic au-delà de l'automatisation des entrepôts tout en renforçant sa position dans l'innovation du secteur de la santé.
Symbotic Inc. (Nasdaq: SYM) hat die Übernahme von OhmniLabs, einem in Silicon Valley ansässigen Unternehmen für Robotiklösungen, das sich auf die Automatisierung im Gesundheitswesen spezialisiert hat, abgeschlossen. Diese strategische Übernahme vereint die Expertise von Symbotic in der großflächigen Automatisierung mit den mobilen Robotern, den Vision- und KI-Lösungen von OhmniLabs.
Gegründet im Jahr 2015, ist OhmniLabs bekannt für seine autonomen Desinfektions- und Telepräsenzroboter, die über ein internes Entwicklungs- und Fertigungsmodell verfügen. Die Akquisition soll die Fähigkeiten von Symbotic über die Automatisierung von Lagern hinaus erweitern und gleichzeitig die Position des Unternehmens im Bereich Innovation im Gesundheitswesen stärken.
- Strategic expansion beyond warehouse automation into healthcare sector
- Acquisition adds autonomous disinfection and telepresence robot technology
- Integration of OhmniLabs' in-house development and manufacturing capabilities
- Access to additional talent pool and robotics expertise
- None.
Insights
This strategic acquisition marks a significant technological expansion for Symbotic, diversifying beyond warehouse automation into healthcare robotics. OhmniLabs' expertise in autonomous disinfection and telepresence robots complements Symbotic's core competencies in AI-enabled robotics. The integration of OhmniLabs' rapid innovation capabilities and manufacturing model with Symbotic's large-scale automation infrastructure creates substantial synergistic potential. This move positions Symbotic to tap into the growing healthcare robotics market while strengthening their existing supply chain solutions. The acquisition brings valuable intellectual property and engineering talent, potentially accelerating Symbotic's product development cycle and expanding their technological moat in automation solutions.
The acquisition of OhmniLabs represents a strategic diversification play for Symbotic, opening up new revenue streams in the lucrative healthcare robotics sector. With a market cap of
Technology Positions Symbotic to Grow with Groundbreaking Product Innovation
WILMINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced that it has completed the acquisition of OhmniLabs, a Silicon Valley-based innovator in the field of robotics solutions for health care.
“Combining Symbotic’s expertise in large-scale automation with OhmniLabs’ ground-breaking mobile robots, vision and A.I. solutions will enable the development of unparalleled automation innovations across different settings,” said Rick Cohen, Executive Chairman and CEO of Symbotic. “We were drawn to OhmniLabs for its impressive talent and industry experience that will enable our expansion beyond the four walls of the warehouse.”
Founded in 2015 by robotics experts, OhmniLabs has pioneered a fully in-house development and manufacturing model, enabling rapid innovation and speed-to-market for cutting-edge robotics solutions. The company is best known for its autonomous disinfection and telepresence robots, which create safer and healthier environments globally. With the strategic acquisition of OhmniLabs’ industry expertise and talented robotics team, Symbotic will be better positioned to both expand its leading automation capabilities for supply chain customers while delivering enhanced innovation to customers in the health care industry.
“OhmniLabs’ mission has been to develop meaningful robotics to provide real-world solutions, and we have made significant progress with the support of our loyal team members and customers. Being a part of Symbotic, a true leader in robotics innovation, will propel this vision forward to deliver cutting-edge solutions that redefine what’s possible in health care, logistics and beyond,” said Jared Go, Co-founder and CTO, OhmniLabs.
ABOUT SYMBOTIC
Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, statements about Symbotic’s acquisition of substantially all of the assets of OhmniLabs and Symbotic’s expectations or predictions of future financial or business performance or conditions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 4, 2024. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.
INVESTOR RELATIONS CONTACT
Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com
MEDIA INQUIRIES
FAQ
What is the strategic purpose of Symbotic (SYM) acquiring OhmniLabs?
What technologies does OhmniLabs bring to Symbotic (SYM)?
How will the OhmniLabs acquisition affect Symbotic's (SYM) market position?
What are OhmniLabs' main products that Symbotic (SYM) has acquired?
